0.50Open0.50Pre Close0 Volume3 Open Interest35.00Strike Price0.00Turnover204.07%IV103.44%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier23DDays to Expiry0.50Extrinsic Value100Contract SizeAmericanOptions Type0.1360Delta0.0244Gamma34.90Leverage Ratio-0.0423Theta0.0012Rho4.75Eff Leverage0.0095Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet